Kityo Anthony, Lee Sang-Ah
Department of Preventive Medicine, School of Medicine, Kangwon National University, Gangwon, Republic of Korea.
Interdisciplinary Graduate Program in Medical Bigdata Convergence, Kangwon National University, Gangwon, Republic of Korea.
Gastroenterol Rep (Oxf). 2024 Jan 9;12:goad074. doi: 10.1093/gastro/goad074. eCollection 2024.
Binge drinking (BD) has been associated with elevated liver enzymes, but the joint association of BD and adiposity with liver enzymes is understudied. We aimed to examine the combined association of BD and obesity with elevated liver enzymes.
Data were obtained from 285,600 patients in the Korean National Health check-up program during 2009-2015. Level I BD (BD I) was defined as alcohol consumption of >60 g (men) or >40 g (women) on one occasion in the previous year. High-intensity BD (HIBD) corresponded to at least two times the BD I levels. General and abdominal obesity were defined by body mass index and waist circumference. Logistic regression was used to examine the independent and joint associations of BD and obesity with elevated alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT) levels. Relative excess risk (RERI), attributable proportion (AP), and synergy index (SI) were calculated to estimate the additive interaction effects.
The mean age was 42.1 ± 0.03 years and 50.2% were women. Elevated ALT [odds ratio (OR) 1.09, 95% confidence interval (CI) 1.02-1.16], AST (OR 1.16, 95% CI 1.11-1.23), and GGT (OR 1.84, 95% CI 1.05-1.94) were associated with HIBD. Higher odds of elevated ALT (OR 3.57, 95% CI 3.43-3.71), AST (OR 3.47, 95% CI 3.37-3.58), and GGT (OR 2.10, 95% CI 1.98-2.12) were observed in individuals with general obesity. A similar trend was observed for abdominal obesity. The RERI, AP, and SI for the interaction effect of BD and general obesity were 23%, 7%, and 13% for elevated AST levels, and 67%, 24%, and 58% for elevated GGT levels, respectively. Similar effects were observed for the interaction between BD and abdominal obesity.
Obesity aggravated the odds of elevated liver AST and GGT levels in HIBD.
暴饮与肝酶升高有关,但暴饮和肥胖与肝酶的联合关联研究较少。我们旨在研究暴饮和肥胖与肝酶升高的联合关联。
数据来自2009 - 2015年韩国国民健康检查项目中的285,600名患者。一级暴饮(BD I)定义为上一年中单次饮酒量男性>60克、女性>40克。高强度暴饮(HIBD)相当于BD I水平的至少两倍。一般肥胖和腹型肥胖通过体重指数和腰围来定义。采用逻辑回归分析暴饮和肥胖与丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)和γ-谷氨酰转移酶(GGT)水平升高的独立和联合关联。计算相对超额危险度(RERI)、归因比例(AP)和协同指数(SI)以估计相加交互作用效应。
平均年龄为42.1±0.03岁,女性占50.2%。HIBD与ALT升高[比值比(OR)1.09,95%置信区间(CI)1.02 - 1.16]、AST升高(OR 1.16,95% CI 1.11 - 1.23)和GGT升高(OR 1.84,95% CI 1.05 - 1.94)相关。一般肥胖个体中ALT升高(OR 3.57,95% CI 3.43 - 3.71)、AST升高(OR 3.47,95% CI 3.37 - 3.58)和GGT升高(OR 2.10,95% CI 1.98 - 2.12)的几率更高。腹型肥胖也观察到类似趋势。BD与一般肥胖交互作用对AST升高的RERI、AP和SI分别为23%、7%和13%,对GGT升高分别为67%、24%和58%。BD与腹型肥胖之间的交互作用也观察到类似效应。
肥胖增加了HIBD患者肝AST和GGT水平升高的几率。